by James Radke, PhD | May 27, 2025
Sanjay Ahuja, MD, Pediatric Hematologist, Chief Medical and Informatics Officer at Innovative Hematology and the Indiana Hemophilia and Thrombosis Center (IHTC), discusses the U.S. Food and Drug Administration (FDA) approval of Qfitlia (fitusiran) for patients with...
by James Radke, PhD | Apr 28, 2025
Shellye Horowitz, a patient with hemophilia and advocate, discusses the impact of hemophilia on women and girls. Hemophilia Hemophilia is a bleeding disorder that slows the blood clotting process. People with this disorder experience prolonged bleeding...
by James Radke, PhD | Apr 11, 2025
A recent study evaluated outcomes of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) patients treated with R-GemOx. DLBCL is a form of non-Hodgkin lymphoma. Lymphomas occur when cells of the immune system, B lymphocytes, grow and multiply uncontrollably....
by James Radke, PhD | May 7, 2024
Alessio Di Fonzo, MD, PhD, neurologist at the University of Milan, discusses research looking into the connection between Gaucher disease and Parkinson’s. Gaucher Disease Gaucher disease refers to a group of inherited metabolic diseases in which harmful...
by James Radke, PhD | Apr 2, 2024
Sarah Cortell Vandersypen, Executive Director of the United MSD Foundation, discusses the organization’s work with multiple sulfatase deficiency. The United MSD Foundation is an international patient advocacy group focused on providing support for...
